Carole Ho Luey June 25, 1934 – April 2, 2014 Resident of Oakland, CA Carole was born on June 25th, 1934 to Chinese parents Harry and Chew Shee Chinn. She was one of nine children growing up in East ...

NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Carole Ho and Elizabeth (Bess) Weatherman to its Board of Directors, effective ...

SOUTH SAN FRANCISCO, Calif., July 22, 2015 /PRNewswire-USNewswire/ -- Denali Therapeutics Inc. ("Denali"), a biotechnology company focused on developing effective therapies for neurodegenerative ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Carole Ho, M.D., Chief ...

Denali Therapeutics Inc. (NASDAQ:DNLI), a $2.1 billion market cap biotech company currently trading at $14.46, saw its Chief Medical Officer Carole Ho sell 3,743 shares of common stock on August 12 ...

Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90% Underscores Royalty Pharma’s commitment to enhanced corporate ...

Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90% Underscores Royalty Pharma's commitment to enhanced corporate ...